TREVENA INC by Trevena, Inc. (TRVN)

About TREVENA INC by Trevena, Inc. (TRVN)

Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Atlanta, GA.

TREVENA INC by Trevena, Inc. News